Blue November Campaign as an annual male self-care strategy for healthy aging

References

• Netto FLM. Aspectos biológicos e fisiológicos do envelhecimento humano e suas implicações na saúde do idoso. Pensar a Prática. 2004;7:75–84.
   Google Scholar
• Gravas S, Bach T, Bachmann A, et al. Guidelines on the managements of non-neurogenic male lower urinary tract symptoms (LUTS), incl. benign prostatic obstruction (BPO). Netherlands: Eur Assoc Urol; 2015; p. 6–97.
   Google Scholar
• Gao Y, Wang M, Zhang H, et al. Are metabolic syndrome and its components associated with lower urinary tract symptoms? Results from a Chinese male population survey. Urology. 2012;79:194–201.
   PubMed Web of Science ®Google Scholar
• Parsons JK, Bergstrom J, Silberstein J, et al. Prevalence and characteristics of lower urinary tract symptoms in men aged ≥80 years. Urology. 2008;72:318–321.
   PubMed Web of Science ®Google Scholar
• St Sauver JL, Jacobsen SJ. Inflammatory mechanisms associated with prostatic inflammation and lower urinary tract symptoms. Curr Prostate Rep. 2008;6:67–73.
   PubMedGoogle Scholar
• De Oliveira MM, Daher DV, Da Silva JL, et al. Men’s health in question: seeking assistance in primary health care. Ciênc Saúde Coletiva. 2015;20:273–278.
   PubMed Web of Science ®Google Scholar
• Brasil. Ministério da Saúde. Envelhecimento e saúde da pessoa idosa. Brasília: Ministério da Saúde; 2007.
   Google Scholar
• Instituto Nacional do Câncer. Posicionamento do Ministério da Saúde acerca da integralidade da saúde do homem no contexto do Novembro Azul. Rio de Janeiro: INCA; 2015;n.001. Available from: www1.inca.gov.br/inca/Arquivos/nota_tecnica_saude_do_homem_ms.pdf
   Google Scholar
• Calogero AE, Burgio G, Condorelli RA, et al. Epidemiology and risk factors of lower urinary tract symptoms/benign prostatic hyperplasia and erectile dysfunction. Aging Male. 2018;2:1–8.
   Web of Science ®Google Scholar
• Lee CL, Kuo HC. Pathophysiology of benign prostate enlargement and lower urinary tract symptoms: Current concepts. Ci Ji Yi Xue Za Zhi. 2017;29:79–83.
   PubMedGoogle Scholar
• Monteiro CA. Velhos e novos males da saúde no Brasil: a evolução do país e suas doenças. São Paulo: Hucitec Nupens/USP; 2000; p. 61–89.
   Google Scholar
• Brasil. Ministério do Planejamento, Orçamento e Gestão. Pesquisa Nacional de Saúde 2013: Ciclos de vida Brasil e grandes regiões. Rio de Janeiro: IBGE; 2015.
   Google Scholar
• Adegun PT, Adebayo PB, Areo PO. Severity of lower urinary tract symptoms among middle aged and elderly nigerian men: impacto on quality of life. Adv Urol. 2016;2016:1.
   Web of Science ®Google Scholar
• Rohrmann S, Katzke V, Kaaks R. Prevalence and progression of lower urinary tract symptoms in an aging population. Urology. 2016;95:158–163.
   PubMed Web of Science ®Google Scholar
• Madersbacher S, Haidinger G, Temml C, et al. Prevalence of lower urinary tract symptoms in austria as assessed by an open survey of 2,096 men. Eur Urol. 1998;34:136–141.
   PubMed Web of Science ®Google Scholar
• Irwin DE, Milsom I, Hunskaar S, et al. Population-based survey of urinary incontinence, overactive bladder and other lower urinary tracts symptoms in five countries: results of the EPIC study. Eur Urol. 2006;50:1306–1314.
   PubMed Web of Science ®Google Scholar
• Kupelian V, Wei JT, O’Leary MP, et al. Prevalence of lower urinary tract symptoms and effect on quality of life in a racially and etnically diverse random sample: the Boston Area Community Health (BACH) Survey. Arch Intern Med. 2006;166:2381–2387.
   PubMed Web of Science ®Google Scholar
• Boyle P, Robertson C, Mazzetta C, et al. The prevalence of lower urinary tract symptoms in men and women in four centres. The UrEpik study. BJU Int. 2003;92:409–414.
   PubMed Web of Science ®Google Scholar
• Orabi H, Albersen M, Lue TF. Association of lower urinary tract symptoms and erectile dyzfunction: pathophysiological aspects and implications for clinical management. Int J Impot Res. 2011;23:99–108.
   PubMed Web of Science ®Google Scholar
• Saigal CS, Wessells H, Pace J, et al. Predictors and prevalence of erectile dysfunction in a racially diverse population. Arch Intern Med. 2006;166:207–212.
   PubMed Web of Science ®Google Scholar
• Braun M, Wassmer G, Klotz T, et al. Epidemiology of erectile dysfunction: results of the 'Cologne Male Survey'. Int J Impot Res. 2000;12:305–311.
   PubMed Web of Science ®Google Scholar
• Rosen R, Altwein J, Boyle P, et al. Lower urinary tract symptoms and male sexual dysfunction the multinational survey of the aging male (MSAM-7). Eur Urol. 2003;44:637–649.
   PubMed Web of Science ®Google Scholar
• Mc Vary KT, Foley J, Slawin KM, et al. The long term effect of doxazosin, finasteride, and the combination on sexual function in men participating in the MTOPS study. J Urol. 2004;171:315. Abstract 1194.
   Web of Science ®Google Scholar
• Li MK, Garcia LA, Rosen R. Lower urinary tract symptoms and male sexual dysfunction in Asia: a survey of ageing men from five Asian countries. BJU Int. 2005;96:1339–1354.
   PubMed Web of Science ®Google Scholar
• Canguven O, Talib RA, El Ansari W, et al. Testosterone therapy has positive effects on anthropometric measures, metabolic syndrome components (obesity, lipid profile, Diabetes Mellitus control), blood indices, liver enzymes and prostate health indicators in elderly hypogonadal men. Andrologia. 2017;49:e12768. doi:10.1111/and.12768
   PubMed Web of Science ®Google Scholar
• Yassin A, Nettleship JE, Talib RA, et al. Effects of testosterone replacement therapy withdrawal and re-treatment in hypogonadal elderly men upon obesity, voidind function and prostate safety parameters. Aging Male. 2016;19:64–69.
   PubMed Web of Science ®Google Scholar
• Meuleman EJ, Legros JJ, Bouloux PM, et al. Effects of long-term oral testosterone undecanoate therapy on urinary symptoms: data from a 1-year, placebo-controlled, dose-ranging trial in aging men with symptomatic hypogonadism. Aging Male. 2015;18:157–163.
   PubMed Web of Science ®Google Scholar
• Yassin DJ, Doros G, Hammerer PG, et al. Long-termtestosterone treatment in elderly men with hypogonadism and erectile dysfunction reduces obesity parameters and improves metabolic syndrome and health-related quality of life. J Sex Med. 2014;11:1567–1576.
   PubMed Web of Science ®Google Scholar
• Shigehara K, Sugimoto K, Konaka H, et al. Androgen replacement therapy contributes to improving lower urinary tract symptoms in patients with hypogonadism and benign prostate hypertrophy: a randomised controlled study. Aging Male. 2011;14:53–58.
   PubMed Web of Science ®Google Scholar
• Park SG, Yeo JK, Cho DY, et al. Impact of metabolic status on the association of serum vitamin D with hypogonadism and lower urinary tract symptoms/benign prostatic hyperplasia. Aging Male. 2018;21:55–59.
   PubMed Web of Science ®Google Scholar
• Canguven O, Talib RA, El Ansari W, et al. Vitamin D treatment improves levels of sexual hormones, metabolic parameters and erectile function in middle-aged vitamin D deficient men. Aging Male. 2017;20:9–16.
   PubMed Web of Science ®Google Scholar
• Espinosa G, Esposito R, Kazzazi A, et al. Vitamin D and benign prostatic hyperplasia - a review. Can J Urol. 2013;20:6820–6825.
   PubMed Web of Science ®Google Scholar
• Ruan L, Zhu JG, Pan C, et al. Association between single nucleotide polymorphism of vitamin D receptor gene FokI polymorphism and clinical progress of benign prostatic hyperplasia. Sci World J. 2015;2015:1.
   Google Scholar
• Yalcinkaya S, Eren E, Eroglu M, et al. Deficiency of vitamin D and elevated aldosterone in prostate hyperplasia. Adv Clin Exp Med. 2014;23:441–446.
   PubMed Web of Science ®Google Scholar
• Hong GS, Shim BS, Chung WS, et al. Correlation between metabolic syndrome and lower urinary tract symptoms of males and females in the aspect of gender specific medicine: a single institutional study. Korean J Urol. 2010;51:631–635.
   PubMedGoogle Scholar
• Park HK, Lee HW, Lee KS, et al. Relationship between lower urinary tract symptoms and metabolic syndrome in a community based elderly population. Urology. 2008;72:556–560.
   PubMed Web of Science ®Google Scholar
• Ohgaki K, Hikima N, Horiuchi K, et al. Association between metabolic syndrome and male lower urinary tract symptoms in Japanese subjects using three sets of criteria for metabolic syndrome and International Prostate Symptom Score. Urology. 2011;77:1432–1438.
   PubMed Web of Science ®Google Scholar
• Temml C, Obermayr R, Marszalek M, et al. Are lower urinary tract symptoms influenced by metabolic syndrome? Urology. 2009;73:544–548.
   PubMed Web of Science ®Google Scholar
• Courtenay WH. Constructions of masculinity and their influence on men's well-being: a theory of gender and health. Soc Sci Med. 2000;50:1385–1401.
   PubMed Web of Science ®Google Scholar
• Schraiber LB, Gomes R, Couto MT. Homens e saúde na pauta da Saúde Coletiva. Ciênc Saúde Coletiva. 2005;10:7–17.
   Google Scholar
• Modesto AAD, Lima RLB, D’Angelis AC, et al. A not-so-blue November: debating screening of prostate cancer and men’s health. Interface (Botucatu). 2018;22:251–262.
   Web of Science ®Google Scholar